Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2010
04/14/2010EP1305418B1 Human monoclonal antibody against hepatitis c virus e2 glycoprotein
04/14/2010EP1015596B2 Fusion proteins comprising hiv-1 tat and/or nef proteins
04/14/2010EP0964693B1 Novel bacteriocins, transport and vector system and method of use thereof
04/14/2010EP0961833B1 Human plasma hyaluronidase
04/14/2010CN1884572B Direct enzyme hydrolysis method for preparing rapeseed peptide using rapeseed cake
04/14/2010CN1769426B Pentose lactobacillus bacteriocin and its special production strain and uses
04/14/2010CN1767852B Antibody vaccine conjugates and uses therefor
04/14/2010CN101694497A Methods of delivery of exogenous proteins to the cytosol and uses thereof
04/14/2010CN101693912A Recombinant plancenta hominis globin renaturation and medicine application protecting alcoholic hepatic injury thereof
04/14/2010CN101693889A Design of beta-sheet proteins with specific binding properties
04/14/2010CN101693742A anti-igf-i receptor antibody
04/14/2010CN101693736A Novel peptides
04/13/2010US7696336 Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
04/13/2010US7696327 for treating septic shock by administering to a patient an effective amount of an antagonist of a PRO285, PRO286 or PRO358 polypeptide
04/13/2010US7696326 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
04/13/2010US7696324 Humanized antibodies
04/13/2010US7696322 Heavy and light chain peptides; generating antibody genes; binding to antigens
04/13/2010US7696321 Molecules and methods for inhibiting shedding of KIM-1
04/13/2010US7696320 treatment and prevention of cell proliferative and inflammatory disorders; drug delivery device is for simultaneously administering to a subject anti-VEGF treatment and anti-EGFR treatment
04/13/2010US7696319 PRO1772 antibodies
04/13/2010US7696317 Mammalian genes; related reagents and methods
04/13/2010US7696316 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
04/13/2010US7696315 Polynucleotides encoding useful polypeptides in Corynebacterium glutamicum ssp. lactofermentum
04/13/2010US7696314 Hypoallergenic mutant polypeptides based on fish parvalbumin
04/13/2010US7696310 Peptides for detection of antibody to Anaplasma phagocytophilum
04/13/2010US7696308 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria
04/13/2010US7696173 fusion protein has trypsin and/or chymotrypsin loop being replaced with a vascular endothelial growth factor binding peptide; a culture product; anticarcinogenic agents, antitumor agents; antiinflammatory agent for treating cartilage and bone disorder; treating dermatitis
04/13/2010US7696172 culture product produced by culturing a recombinant host cell under suitable conditions to express the polypeptide; has an oncogenic activity; treating liver disorder cirrhosis, or pancreas disorder
04/13/2010US7696167 Cyclic peptide compound
04/13/2010US7696157 Plurality of isolated erythropoietin-like molecules; reperfusion injuries; antiischemic, antihypoxic, antiinflammatory gents; neurodegenerative or nervous system disorders; genetic engineering and expression
04/13/2010US7695965 Exposing embryonic stem cells culture to cells expressing activin receptor-like kinase (ALK) receptor, transplanting tissues into mammal, recovering insulin secreting cells; endocrine cell therapy
04/13/2010US7695962 Polypeptides and nucleic acids encoding same
04/13/2010US7695961 Insulin related transcription factor and uses thereof
04/13/2010US7695946 Polynucleotides encoding useful polypeptides in Corynebacterium glutamicum ssp. lactofermentum
04/13/2010US7695945 Immobilized microbial nitrilase for production of glycolic acid
04/13/2010US7695940 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
04/13/2010US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
04/13/2010US7695938 Vectors and recombinant host cells comprising nucleic acid molecules encoding Fibroblast Growth Factor-like polypeptides
04/13/2010US7695937 Polynucleotides encoding C-type lectin polypeptides and methods of use thereof
04/13/2010US7695936 Knobs and holes heteromeric polypeptides
04/13/2010US7695935 Using modified blood coagulation factor as therapeutic treatment for blood disorders and excessive bleeding due to tissue damage or trauma
04/13/2010US7695934 Pure polypeptide containing a fragment capable of binding to and inducing apoptosis in a carcinoma cell; Tumor Necrosis Factor Related ligand "TRELL; gene therapy to treat tumors, autoimmune and inflammatory diseases or inherited genetic disorders
04/13/2010US7695933 SM38 nucleic acid molecules
04/13/2010US7695931 Carotenoid hydroxylase gene, method for preparing hydroxylated carotenoid, and novel geranylgeranyl pyrophosphate synthase
04/13/2010US7695928 Disheveled PDZ modulators
04/13/2010US7695920 Methods of screening compounds binding to presynaptic protein CAST
04/13/2010US7695751 Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof
04/13/2010US7695715 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
04/13/2010CA2472280C Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants
04/13/2010CA2449747C Use of fkbp chaperones as expression tool
04/13/2010CA2372468C Compounds exhibiting an antibiotic activity
04/13/2010CA2350080C Novel serine protease bssp2
04/13/2010CA2348773C Functional antagonists of hedgehog activity
04/13/2010CA2318482C Il-18 receptors
04/13/2010CA2257357C Humanized antibodies with modified glycosylation
04/13/2010CA2203528C Methods and kits using macrophage stimulating protein
04/13/2010CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies
04/13/2010CA2189015C Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
04/13/2010CA2144056C Cd27 ligand
04/13/2010CA2089229C Cd40cr receptor and ligands therefor
04/13/2010CA2077154C Hcmv-specific peptides, agents therefor and the use thereof
04/08/2010WO2010038831A1 Method, composition and kit for detecting diabetic complications accompanied by cell proliferation
04/08/2010WO2010038830A1 Method, composition and kit for detecting tissue disorders induced by atrophy of collagen fibers
04/08/2010WO2010038829A1 Method, composition and kit for detecting diabetic peripheral vascular disorder
04/08/2010WO2010038802A1 Host, transformant, method for producing the transformant, and method for producing heterogeneous protein containing o-glycoside type sugar chain
04/08/2010WO2010038789A1 Antibody capable of binding to envelope protein 2 of hepatitis c virus, and method for identifying genotype of hepatitis c virus using same
04/08/2010WO2010038719A1 Method for producing purified influenza virus antigen
04/08/2010WO2010038707A1 Large-scale protein sample collection method
04/08/2010WO2010038145A2 Kit for the optimisation of protein synthesis/secretion
04/08/2010WO2010037208A1 Production of products of pharmaceutical interest in plant cell cultures
04/08/2010WO2008152537A3 Humanized monoclonal antibodies
04/08/2010US20100088782 Seed enhancement by combinations of pyruvate kinases
04/08/2010US20100088778 Methods of Treatment, and Diagnosis of Epilepsy by Detecting Mutations in the SCN1A Gene
04/08/2010US20100088776 Processes for producing polyunsaturated fatty acids in transgenic organisms
04/08/2010US20100087677 Compositions of tRNA and Uses Thereof
04/08/2010US20100087625 Method of enhancing recombinant protein production
04/08/2010US20100087624 Methods for making recombinant proteins using apoptosis inhibitors
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100087510 Novel Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
04/08/2010US20100087377 Peptide facilitating the entry of a linked molecule into a mammalian cancer cell; copper binding protein; inhibit the development of premalignant lesions in mammalian tissue
04/08/2010US20100087371 Transglutaminase Variants with Improved Specificity
04/08/2010US20100086985 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
04/08/2010US20100086972 Process for the production of biodegradable, functionalised polymer particles and use thereof as pharmaceutical supports
04/08/2010US20100086971 Growth medium for clostridium histolyticum
04/08/2010US20100086970 Thermus scotoductus nucleic acid polymerases
04/08/2010US20100086969 Antibodies That Bind to EphA2 and Methods of Use Thereof
04/08/2010US20100086968 Lactic acid bacteria strain and its use for the protection of food products
04/08/2010US20100086967 Cell growth
04/08/2010US20100086966 Feedback resistant acetohydroxy acid synthethase mutants
04/08/2010US20100086942 Compounds
04/08/2010US20100086568 Modification of allergens
04/08/2010US20100086556 Use of hemagglutinin of the african swine fever virus as an adjuvant
04/08/2010US20100086552 Allergen-binding ige monoclonal antibodies and method for preparing hypoallergens
04/08/2010US20100086545 Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
04/08/2010US20100086538 Antibody Molecules Which Bind to Human IL-17
04/08/2010US20100086516 Cytokine receptor chain
04/08/2010DE102006057724B4 Mikrobielles Verfahren zur Herstellung von Enzymen A process for the microbial production of enzymes
04/08/2010CA2738982A1 Antibody binding to envelope protein 2 of hepatitis c virus and method for identifying genotype of hepatitis c virus using the same
04/08/2010CA2738571A1 Production of products of pharmaceutical interest in plant cell cultures
04/07/2010EP2172557A1 Filamentous fungal mutants with improved homologous recombination efficiency